Related by context. Frequent words. (Click for all words.) 65 pharmacodynamic effects 64 nitazoxanide 64 Traficet EN 64 phase IIb clinical 63 sapacitabine 63 HGS ETR1 63 CR# vcMMAE 63 mcg dose 63 Phase Ib clinical 63 GSK# [001] 62 Diamyd ® 62 OncoVEX GM CSF 62 RGB # 62 elotuzumab 62 nab paclitaxel 62 phase IIa 62 GLPG# 62 SCH # 62 adecatumumab 62 BAY #-# 62 administered subcutaneously 62 Phase 2a trial 62 tesmilifene 61 Panzem R 61 GVAX 61 phase 2a 61 CCX# 61 Cloretazine R VNP#M 61 ponatinib 61 dose regimens 61 PREZISTA r 61 placebo controlled Phase 61 heavily pretreated 61 dose titration 61 PRECiSE 61 tanespimycin 60 celgosivir 60 MIRCERA 60 glufosfamide 60 dose cohorts 60 patients evaluable 60 placebo controlled clinical trials 60 KRN# 60 dose escalation trial 60 double blinded placebo 60 mg kg dose 60 decitabine 60 secondary efficacy endpoints 60 thymalfasin 60 TELCYTA 60 pafuramidine 60 relapsed multiple myeloma 60 vicriviroc 60 talactoferrin 60 NVA# 60 Allovectin 7 R 60 methylnaltrexone 60 axitinib 59 custirsen 59 deforolimus 59 Phase 1b 59 SRT# [003] 59 Azedra 59 Cethromycin 59 IMGN# 59 optimal dosing 59 figitumumab 59 RRMS patients 59 CYT# 59 sustained virologic response 59 abiraterone acetate 59 peginterferon 59 valopicitabine 59 PS# [001] 59 PXD# 59 advanced carcinoid 59 OXi# 59 active comparator 59 INGN 59 Anthim 59 MAP# 59 Gabapentin GR 59 Phase Ib 58 Neuradiab 58 palifosfamide 58 fulvestrant 58 safety tolerability pharmacokinetics 58 mRCC 58 maribavir 58 APOPTONE 58 eniluracil 58 Ostarine 58 pertuzumab 58 squalamine 58 Phase 2b study 58 dirucotide 58 romidepsin 58 Phase 1a 58 Sym# 58 RSD# 58 Phenoptin